AKT isoform-specific expression and activation across cancer lineages

BMC Cancer
Jue WangZhiyong Ding

Abstract

Aberrant AKT activation is prevalent across human cancer lineages, providing an important therapeutic target. AKT comprises three isoforms that mediate critical non-redundant, even opposing functions in cancer pathophysiology. Therefore, targeting specific AKT isoforms in particular cancers may be more effective than pan-AKT inhibition while avoiding disadvantages of pan-AKT inhibition. Currently, AKT isoform-specific expression and activation in cancer are not clearly characterized. We systematically characterized AKT isoform-specific expression and activation in 211 cancer cell lines derived from different lineages and genetic backgrounds using a reverse-phase protein array platform. We found that phosphorylation, but not expression, of AKT1 and AKT2 was coordinated in most but not all cells. Different cancer lineages displayed differential AKT1 and AKT2 expression and phosphorylation. A PIK3CA hotspot mutation H1047R but not E545K was associated with selective activation of AKT2 but not AKT1. Our study identified and validated AKT isoform-specific expression and phosphorylation in certain cell lines and demonstrated that genetic changes can affect AKT isoform-specific activation. These results provide a more precise understa...Continue Reading

References

Aug 22, 1995·International Journal of Cancer. Journal International Du Cancer·A BellacosaJ R Testa
Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·J Q ChengJ R Testa
Sep 6, 1996·The Journal of Biological Chemistry·A D KohnR A Roth
Mar 16, 2004·Science·Yardena SamuelsVictor E Velculescu
May 8, 2004·Trends in Biochemical Sciences·Derek P BrazilBrian A Hemmings
Jan 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Sohye KangPeter K Vogt
Jun 14, 2005·Cancer Cell·Yardena SamuelsVictor E Velculescu
Dec 3, 2005·Cancer Research·Steven J IsakoffJoan S Brugge
Dec 13, 2005·Nature Reviews. Drug Discovery·Bryan T HennessyGordon B Mills
Dec 21, 2005·The Journal of Cell Biology·Hanna Y IrieJoan S Brugge
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hong LiuMina J Bissell
Jul 19, 2006·Nature Reviews. Genetics·Jeffrey A EngelmanLewis C Cantley
Jul 3, 2007·Cell·Brendan D Manning, Lewis C Cantley
Feb 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·John P GustinBen Ho Park
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Kajsa EricsonNickolas Papadopoulos
Oct 12, 2011·Advances in Biological Regulation·Alex Toker
Oct 26, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy A YapAnthony W Tolcher
Jun 23, 2012·Nature·Shantanu BanerjiMatthew Meyerson
May 3, 2013·Nature·Cyriac KandothDouglas A Levine
Jul 28, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Julia A BeaverJosh Lauring
Dec 18, 2013·Cancer Research·Y Rebecca ChinAlex Toker
May 6, 2014·Advances in Biological Regulation·Alex Toker, Sandra Marmiroli
May 20, 2014·Cancer Discovery·Y Rebecca ChinAlex Toker
Sep 19, 2014·Biochemical Society Transactions·Abbe R Clark, Alex Toker
Mar 5, 2015·Proceedings of the National Academy of Sciences of the United States of America·Kristen M TurnerWei Zhang
May 20, 2016·Cancer Research·Poornima Bhat-NakshatriHarikrishna Nakshatri

❮ Previous
Next ❯

Citations

Oct 9, 2019·Expert Opinion on Investigational Drugs·Maryam Shariati, Funda Meric-Bernstam
Jun 20, 2019·International Journal of Molecular Sciences·Marwa El SheikhIl-Keun Kong
Mar 10, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Yun MaoShijie Zhu
Nov 23, 2019·Cell Communication and Signaling : CCS·Nico Hinz, Manfred Jücker
Mar 20, 2020·Beilstein Journal of Nanotechnology·Gayathri KandasamyUma Maheswari Krishnan
Jan 1, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Tijs MerckaertJan Gettemans
Apr 10, 2021·Frontiers in Oncology·Akanksha KhandelwalAklank Jain
Jul 3, 2021·Current Issues in Molecular Biology·Crina E TironIoana Grigoras

❮ Previous
Next ❯

Methods Mentioned

BETA
protein array
electrophoresis
xenograft

Software Mentioned

ImageJ

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.